2019
DOI: 10.2174/1872211312666181022150435
|View full text |Cite
|
Sign up to set email alerts
|

Self-Emulsifying Drug Delivery System of Simvastatin: Formulation Development, Optimization by Box- Behnken Design, In-Vitro and In-Situ Single-Pass Intestinal Perfusion (SPIP) Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The most commonly-known dosage form of SIM in the market is the film-coated tablets used as a controlled release lipid-regulating drug 8 . Other formulations were described such as self-emulsifying drug delivery systems 9,10 , nanoparticles 7,[11][12][13] , buccal film of SIM 14 floating tablets 15 and dry powder inhaler 16 .…”
Section: Introductionmentioning
confidence: 99%
“…The most commonly-known dosage form of SIM in the market is the film-coated tablets used as a controlled release lipid-regulating drug 8 . Other formulations were described such as self-emulsifying drug delivery systems 9,10 , nanoparticles 7,[11][12][13] , buccal film of SIM 14 floating tablets 15 and dry powder inhaler 16 .…”
Section: Introductionmentioning
confidence: 99%
“…Simvastatin (SIM) is a white to off-white, non-hygroscopic, crystalline powder that exhibits extensive polymorphism (polymorphs I, II, and III have been reported, with form I being the more stable form) . It is categorized as a Biopharmaceutics Classification System (BCS) class II compound having very low aqueous solubility and high permeability, while the gastrointestinal dissolution is the rate-limiting step for its in vivo bioavailability. In addition to the cholesterol-lowering properties, recent studies have also provided evidence that SIM (along with other statins) exhibits a significant therapeutic effect in the treatment of several other conditions such as cancer and skin diseases. , In this context, and despite its long clinical use, substantial efforts are still being made in order to develop new solid dosage forms for SIM with enhanced aqueous solubility and bioavailability after oral administration. …”
Section: Introductionmentioning
confidence: 99%